Robert E. Hurst, PhD
Co-Founder, Chief Scientific Officer
Bob brings broad experience in novel therapeutic approaches to prevention and treatment of metastasis, biomarkers for diagnosis and prognosis of malignancy and the carcinogenic process.
Bob is Professor Emeritus, Department of Urology, University of Oklahoma Health Sciences Center. He was also a founder of DormaTarg.
Bob has published over 150 peer reviewed papers and is listed as an inventor on 11 patents to date. In 2009 he was named “Innovator of the Year” by the “Oklahoma Journal Record”, the State’s business newspaper. Bob is a Fellow of the American Association for the Advancement of Science. Bob earned his Bachelor’s of Science from Auburn University and his Ph.D. in biochemistry from Florida State University.